Reasons for Discontinuation or Change of Selective Serotonin Reuptake Inhibitors in Online Drug Reviews

Golder, Su orcid.org/0000-0002-8987-5211, Medaglio, Dominique, O'Connor, Karen et al. (3 more authors) (2023) Reasons for Discontinuation or Change of Selective Serotonin Reuptake Inhibitors in Online Drug Reviews. JAMA network open. e2323746. ISSN 2574-3805

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2023 Golder S. et al.

Keywords: United States,Male,Humans,Female,Selective Serotonin Reuptake Inhibitors/adverse effects,Pharmaceutical Preparations,Mental Disorders/drug therapy,Anxiety
Dates:
  • Published: 31 July 2023
  • Accepted: 23 May 2023
Institution: The University of York
Academic Units: The University of York > Faculty of Sciences (York) > Health Sciences (York)
Depositing User: Pure (York)
Date Deposited: 26 Jul 2023 09:40
Last Modified: 16 Oct 2024 19:20
Published Version: https://doi.org/10.1001/jamanetworkopen.2023.23746
Status: Published
Refereed: Yes
Identification Number: 10.1001/jamanetworkopen.2023.23746
Open Archives Initiative ID (OAI ID):

Download

Filename: golder_2023_oi_230698_1688756177.57698.pdf

Description: Reasons for Discontinuation or Change of Selective Serotonin Reuptake Inhibitors in Online Drug Reviews

Licence: CC-BY 2.5

Export

Statistics